159 related articles for article (PubMed ID: 27648372)
21. Radiosynthesis of [
Yang L; Brooks AF; Makaravage KJ; Zhang H; Sanford MS; Scott PJH; Shao X
ACS Med Chem Lett; 2018 Dec; 9(12):1274-1279. PubMed ID: 30613339
[TBL] [Abstract][Full Text] [Related]
22. Agonist activity of naloxone benzoylhydrazone at recombinant and native opioid receptors.
Olianas MC; Concas D; Onali P
Br J Pharmacol; 2006 Feb; 147(4):360-70. PubMed ID: 16402046
[TBL] [Abstract][Full Text] [Related]
23. Involvements of mu- and kappa-opioid receptors in morphine-induced antinociception in the nucleus accumbens of rats.
Xiong W; Yu LC
Neurosci Lett; 2006 May; 399(1-2):167-70. PubMed ID: 16490317
[TBL] [Abstract][Full Text] [Related]
24. Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective.
Zhang L; Zhang JT; Hang L; Liu T
Front Pharmacol; 2020; 11():1078. PubMed ID: 32760281
[TBL] [Abstract][Full Text] [Related]
25. Maladaptive behavioral regulation in alcohol dependence: Role of kappa-opioid receptors in the bed nucleus of the stria terminalis.
Erikson CM; Wei G; Walker BM
Neuropharmacology; 2018 Sep; 140():162-173. PubMed ID: 30075159
[TBL] [Abstract][Full Text] [Related]
26. Kappa and delta opioid receptors are expressed but down-regulated in fibroblast-like synoviocytes of patients with rheumatoid arthritis and osteoarthritis.
Shen H; Aeschlimann A; Reisch N; Gay RE; Simmen BR; Michel BA; Gay S; Sprott H
Arthritis Rheum; 2005 May; 52(5):1402-10. PubMed ID: 15880345
[TBL] [Abstract][Full Text] [Related]
27. μ and κ opioid receptor distribution in the monogamous titi monkey (Callicebus cupreus): implications for social behavior and endocrine functioning.
Ragen BJ; Freeman SM; Laredo SA; Mendoza SP; Bales KL
Neuroscience; 2015 Apr; 290():421-34. PubMed ID: 25637809
[TBL] [Abstract][Full Text] [Related]
28. κ-Opioid receptor in the nucleus is a novel prognostic factor of esophageal squamous cell carcinoma.
Zhang YF; Xu QX; Liao LD; Xu XE; Wu JY; Shen J; Wu ZY; Shen JH; Li EM; Xu LY
Hum Pathol; 2013 Sep; 44(9):1756-65. PubMed ID: 23574786
[TBL] [Abstract][Full Text] [Related]
29. Fluorine-18-Labeled Antagonist for PET Imaging of Kappa Opioid Receptors.
Cai Z; Li S; Pracitto R; Navarro A; Shirali A; Ropchan J; Huang Y
ACS Chem Neurosci; 2017 Jan; 8(1):12-16. PubMed ID: 27741398
[TBL] [Abstract][Full Text] [Related]
30. Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting.
Zhou L; Stahl EL; Lovell KM; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
Neuropharmacology; 2015 Dec; 99():131-41. PubMed ID: 26160155
[TBL] [Abstract][Full Text] [Related]
31. NPY-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats.
Israel Y; Kandov Y; Khaimova E; Kest A; Lewis SR; Pasternak GW; Pan YX; Rossi GC; Bodnar RJ
Peptides; 2005 Jul; 26(7):1167-75. PubMed ID: 15949635
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and Structure-Activity Relationships of (-)-
Pasquinucci L; Parenti C; Amata E; Georgoussi Z; Pallaki P; Camarda V; Calò G; Arena E; Montenegro L; Turnaturi R
Pharmaceuticals (Basel); 2018 May; 11(2):. PubMed ID: 29734749
[TBL] [Abstract][Full Text] [Related]
33. Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys.
Ko MC; Lee H; Harrison C; Clark MJ; Song HF; Naughton NN; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2003 Jul; 306(1):179-86. PubMed ID: 12676881
[TBL] [Abstract][Full Text] [Related]
34. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.
Kreek MJ; Schluger J; Borg L; Gunduz M; Ho A
J Pharmacol Exp Ther; 1999 Jan; 288(1):260-9. PubMed ID: 9862779
[TBL] [Abstract][Full Text] [Related]
35. Antinociceptive profile of LP1, a non-peptide multitarget opioid ligand.
Parenti C; Turnaturi R; Aricò G; Marrazzo A; Prezzavento O; Ronsisvalle S; Scoto GM; Ronsisvalle G; Pasquinucci L
Life Sci; 2012 Jun; 90(25-26):957-61. PubMed ID: 22580287
[TBL] [Abstract][Full Text] [Related]
36. Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons.
Margolis EB; Hjelmstad GO; Bonci A; Fields HL
J Neurosci; 2003 Nov; 23(31):9981-6. PubMed ID: 14602811
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological profile of TAN-452, a novel peripherally acting opioid receptor antagonist for the treatment of opioid-induced bowel syndromes.
Suzuki T; Sawada T; Kawai K; Ishihara Y
Life Sci; 2018 Dec; 215():246-252. PubMed ID: 30036489
[TBL] [Abstract][Full Text] [Related]
38. Design of high affinity cyclic pentapeptide ligands for kappa-opioid receptors.
Przydzial MJ; Pogozheva ID; Ho JC; Bosse KE; Sawyer E; Traynor JR; Mosberg HI
J Pept Res; 2005 Nov; 66(5):255-62. PubMed ID: 16218993
[TBL] [Abstract][Full Text] [Related]
39. Ethanol and Naltrexone Have Distinct Effects on the Lateral Nano-organization of Mu and Kappa Opioid Receptors in the Plasma Membrane.
Tobin SJ; Wakefield DL; Terenius L; Vukojević V; Jovanović-Talisman T
ACS Chem Neurosci; 2019 Jan; 10(1):667-676. PubMed ID: 30418735
[TBL] [Abstract][Full Text] [Related]
40. Cloning and bioinformatics of amphibian mu, delta, kappa, and nociceptin opioid receptors expressed in brain tissue: evidence for opioid receptor divergence in mammals.
Stevens CW; Brasel CM; Mohan S
Neurosci Lett; 2007 Jun; 419(3):189-94. PubMed ID: 17452077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
